REG - Wells Fargo & Co - Publication of Final Terms

Wells Fargo & CoAnnouncement

07/06/2023 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230607:nRSG8740Ba&default-theme=true

RNS Number : 8740B  Wells Fargo & Company  07 June 2023

Publication of Amended Pricing Supplement

The following amended Pricing Supplement is available for viewing:

·        Pricing Supplement dated 5 June 2023 in relation to the USD
80,000,000 Credit Linked Notes (the "Notes") issued by Wells Fargo &
Company (the "Issuer") under the U.S.$10,000,000,000 Euro Medium Term Note
Programme of the Issuer (the "Amended Pricing Supplement").

The Amended Pricing Supplement amends and restates the pricing supplement
dated 6 August 2015 in respect of the Notes.

To view the Amended Pricing Supplement, please paste the following URL into
the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/8740B_1-2023-6-6.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/8740B_1-2023-6-6.pdf)

A copy of the Amended Pricing Supplement will be submitted to the National
Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

For further information, please contact

Mary E. Schaffner

Senior Vice President and Senior Company Counsel

Wells Fargo & Company

+1-612-667-2367

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Amended Pricing Supplement
or Base Prospectus (collectively, the "Prospectus") may be addressed to and/or
targeted at persons who are residents of particular countries (specified in
the Prospectus) only and is not intended for use and should not be relied upon
by any person outside these countries and/or to whom the offer contained in
the Prospectus is not addressed. Prior to relying on the information contained
in the Prospectus you must ascertain from the Prospectus whether or not you
are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above
requirement.

DISCLAIMER - SECURITIES ACT REGISTRATION

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act"), or any relevant
securities laws of any state of the United States and are subject to U.S. tax
law requirements. Subject to certain exemptions, the Notes may not be offered,
sold or delivered within the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PFTNKABPKBKBBAK